|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Market Summary
News
IPOs
Company Profiles
Companies
Events
Research Store
Biotech Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
Vitro Diagnostics (VODG) Launches New Stem Cell Products for Clinical Use & Presents Webinar with HemoGenix Inc.
7/20/2011 8:30:22 AM
GOLDEN, Colo.--(BUSINESS WIRE)--Vitro Diagnostics, Inc. (OTCQB: VODG), dba Vitro Biopharma, announced the commercial launch of several new stem cell products including those with application to clinical studies. The new products were presented to the scientific community in a webinar jointly produced with our strategic partner, HemoGenix®, Inc. entitled “Mesenchymal Stem/Stromal Cells: Advances in Assays and Growth/Differentiation Media.” Vitro’s catalog now consists of adult stem cells, their fluorescent derivatives, and an expanded menu of tools for cellular reprogramming of adult cells to the functional equivalent of embryonic stem cells. Vitro now offers several additional formulations of its highly competitive MSCGro™ stem cell media product line together with advanced analytical tools, jointly manufactured with HemoGenix®, Inc., for the determination of stem cell quality, potency and response to toxic agents.
|
|
|
|
|
|
|
|
|
|
|